Issue 15, 2026, Issue in Progress

ZrO2-supported LaCo0.5Cu0.5O3 composites for enhanced peroxymonosulfate activation and efficient degradation of ibuprofen

Abstract

The tight packing of perovskite particles and secondary pollution limit their peroxymonosulfate (PMS) activation efficiency for water treatment. To address this, an eco-friendly and stable LaCo0.5Cu0.5O3/ZrO2 (LCCZ) catalyst is synthesized via a sol–gel method. Cu is introduced into the B-site of LaCoO3 to form LaCo0.5Cu0.5O3 (LaCoCu55) and then supported on ZrO2. Characterization results confirmed the successful synthesis and dispersion of catalyst. Cu doping promoted Co3+/Co2+ and Cu2+/Cu+ redox cycles, while the ZrO2 support enhanced active site exposure. Under optimized conditions (25 °C, 20 mg L−1 ibuprofen (IBU), 0.1 g L−1 LCCZ, 0.75 mM PMS, pH 7), IBU was completely degraded within 30 min. The catalyst exhibited good recyclability with minimal Co leaching (0.522 mg L−1). After modification to form LCCZ, the enhanced redox cycling between Cu and Co ions, coupled with improved accessibility of active sites to PMS facilitated by the ZrO2 support, synergistically activated PMS to generate substantial amounts of reactive species including 1O2 and ˙SO4. IBU degrades via 1O2 and ˙SO4-mediated oxidation, forming benzene-ring intermediates before mineralization to CO2 and H2O. This work guides perovskite catalyst design for IBU wastewater treatment by PMS activation.

Graphical abstract: ZrO2-supported LaCo0.5Cu0.5O3 composites for enhanced peroxymonosulfate activation and efficient degradation of ibuprofen

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
10 Nov 2025
Accepted
26 Feb 2026
First published
11 Mar 2026
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2026,16, 13669-13681

ZrO2-supported LaCo0.5Cu0.5O3 composites for enhanced peroxymonosulfate activation and efficient degradation of ibuprofen

Z. Zhan, X. Yu, J. Wan, X. Wang, J. Xiao, Y. Wu and Z. Yan, RSC Adv., 2026, 16, 13669 DOI: 10.1039/D5RA08658B

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements